Long term follow up of spinal trabecular bone mineral density in women with non-steroid treated rheumatoid arthritis.
作者信息
Cooper A M, O'Sullivan M M, Clements D, Compston J E, Evans W D, Evans C
出版信息
Ann Rheum Dis. 1994 Feb;53(2):149. doi: 10.1136/ard.53.2.149.
Abstract
摘要
相似文献
1
Long term follow up of spinal trabecular bone mineral density in women with non-steroid treated rheumatoid arthritis.非甾体类药物治疗的类风湿关节炎女性患者脊柱小梁骨密度的长期随访
Ann Rheum Dis. 1994 Feb;53(2):149. doi: 10.1136/ard.53.2.149.
2
Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis.未接受类固醇治疗的类风湿性关节炎患者的脊柱小梁骨矿物质含量
Ann Rheum Dis. 1988 Aug;47(8):660-4. doi: 10.1136/ard.47.8.660.
3
Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.类风湿关节炎患者骨密度的评估。疾病活动度和糖皮质激素治疗的影响。
Rev Rhum Engl Ed. 1997 Jul-Sep;64(7-9):451-8.
4
Bone mineral density of the lumbar spine in patients with advanced rheumatoid arthritis. Influence of functional capacity and corticosteroid use.晚期类风湿关节炎患者腰椎的骨矿物质密度。功能能力和皮质类固醇使用情况的影响。
Scand J Rheumatol. 1999;28(6):363-7. doi: 10.1080/03009749950155355.
5
Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.比较类风湿关节炎患者和对照组外周定量 CT 前臂骨密度与 DXA 的差异。
Osteoporos Int. 2017 Apr;28(4):1271-1277. doi: 10.1007/s00198-016-3850-x. Epub 2016 Dec 10.
6
Effects of glucocorticoids on bone mineral density in rheumatoid arthritis patients. A longitudinal study.糖皮质激素对类风湿关节炎患者骨密度的影响。一项纵向研究。
Arch Orthop Trauma Surg. 1999;119(1-2):18-21. doi: 10.1007/s004020050348.
7
Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis.类固醇治疗的类风湿性关节炎患者的椎体骨折风险及其与骨密度的关系。
Ann Rheum Dis. 1995 Oct;54(10):801-6. doi: 10.1136/ard.54.10.801.
8
Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.在类风湿关节炎相关性骨质疏松症中，无论是否进行双膦酸盐预处理，地诺单抗均可显著提高骨密度：地诺单抗可提高类风湿关节炎相关性骨质疏松症的骨密度。
Arch Osteoporos. 2017 Sep 21;12(1):80. doi: 10.1007/s11657-017-0371-y.
9
Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.骨小梁评分（TBS）和四肢肌肉质量低导致的骨微结构损伤：长期患有类风湿关节炎的女性发生椎体和非椎体骨折的主要危险因素。
Osteoporos Int. 2024 May;35(5):819-830. doi: 10.1007/s00198-024-07026-3. Epub 2024 Jan 25.
10
Reduced bone formation in non-steroid treated patients with rheumatoid arthritis.类风湿关节炎非甾体治疗患者的骨形成减少。
Ann Rheum Dis. 1989 Jun;48(6):483-7. doi: 10.1136/ard.48.6.483.
本文引用的文献
1
Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.辅助雌激素治疗可提高绝经后类风湿关节炎女性的骨密度。
Ann Rheum Dis. 1993 Apr;52(4):302-5. doi: 10.1136/ard.52.4.302.
2
Quantitative computed tomography for prediction of vertebral fracture risk.定量计算机断层扫描用于预测椎体骨折风险。
Bone. 1985;6(1):1-7. doi: 10.1016/8756-3282(85)90399-0.
3
Spinal trabecular bone mineral content in patients with non-steroid treated rheumatoid arthritis.未接受类固醇治疗的类风湿性关节炎患者的脊柱小梁骨矿物质含量
Ann Rheum Dis. 1988 Aug;47(8):660-4. doi: 10.1136/ard.47.8.660.
4
A theoretical analysis of the accuracy of single-energy CT bone-mineral measurements.单能量CT骨矿物质测量准确性的理论分析
Phys Med Biol. 1988 Oct;33(10):1113-27. doi: 10.1088/0031-9155/33/10/002.
5
Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.类风湿关节炎绝经后骨质流失：雌激素与雄激素的作用
J Rheumatol. 1992 Mar;19(3):357-61.
6
Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss.
J Bone Miner Res. 1992 Sep;7(9):1063-9. doi: 10.1002/jbmr.5650070909.
Zotero 插件